T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy
Journal of Cellular and Molecular Medicine · 2026-02 · 30 (3)
DOI: 10.1111/jcmm.71044 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 06.02.2026. Verfasst von Kosar Nouri und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, T-Cell Exhaustion, Liver Neoplasms, Immunotherapy. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 205 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC), accounting for over 90% of primary liver cancers, remains a major global challenge for healthcare professionals. While immunotherapy has transformed the landscape of cancer treatment, its success is often limited by immune resistance, particularly through T cell exhaustion which remains a major barrier to effective immune responses in solid tumours, including HCC. As tumours progress, T cells undergo a gradual loss of functionality due to continuous antigen exposure and fail to exert effective anti‐tumour responses. During this process, alterations in the epigenome, transcriptome, signalling pathways, and tumour metabolome, in addition to interactions with other cells in the tumour microenvironment, efficiently contribute to T cell exhaustion. Restoring T cell function brings hope for improving therapy outcomes and providing new treatment modalities for HCC patients. In this review, we explore the key cellular and molecular mechanisms driving T cell exhaustion, including the roles of immunosuppressive cells, metabolic stress, and epigenetic alterations focusing on HCC. We also discuss current and emerging strategies aimed at preventing or reversing T cell exhaustion, such as epigenetic modulation, immune checkpoint blockade, metabolic reprogramming, and combination therapies. Understanding these interconnected pathways is critical for designing more effective immunotherapy‐based approaches for liver cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.
- Biological Products and Blood Safety Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
- Department of Allergy and Clinical Immunology, Mofid Children's Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Laboratory of Pediatric Hepatology and Cell Therapy, Institute of Experimental and Clinical Research, UCLouvain, Brussels, Belgium.
- Private University of Marrakesh, Marrakesh, Morocco.
ORCID-Profile: Mustapha Najimi, Massoud Vosough
Zitieren
APA
Nouri, K., Asadollahei, N., Haghir-Sharif-Zamini, Y., Seydi, H., Salehi, M., Mesdaghi, M., Najimi, M., & Vosough, M. (2026). T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. Journal of Cellular and Molecular Medicine, 30(3). https://doi.org/10.1111/jcmm.71044
Vancouver
Nouri K, Asadollahei N, Haghir-Sharif-Zamini Y, Seydi H, Salehi M, Mesdaghi M, et al. T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy. Journal of Cellular and Molecular Medicine. 2026;30(3). doi:10.1111/jcmm.71044
BibTeX
@article{Nouri2026,
author = {Nouri, Kosar and Asadollahei, Negar and Haghir-Sharif-Zamini, Yasamin and Seydi, Homeyra and Salehi, Mahsa and Mesdaghi, Mehrnaz and Najimi, Mustapha and Vosough, Massoud},
title = {T Cell Exhaustion in Hepatocellular Carcinoma: A Substantial Barrier in Immunotherapy},
journal = {Journal of Cellular and Molecular Medicine},
year = {2026},
volume = {30},
number = {3},
doi = {10.1111/jcmm.71044}
}
EUVIMED